BEIJING, May 30, 2024 /PRNewswire/ -- This is a report from China.org.cn about the Shaolin Temple: ...

BOSTON, June 1, 2024 /PRNewswire/ -- Immunocan announces significant progress in the construction of...

Poster presentation features the interim data from an ongoing Phase 1b cli...

Separate & Distinct from HARMONi-2 Announcement, HARMONi-A Showed Clinically Meaningful and Stat...

The largest graduating class in Duke-NUS' history saw 90 graduates, including the first-ever Mast...

SAN FRANCISCO and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") ...

BEIJING and SHANGHAI and CHICAGO, June 2, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-...

EMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demons...

SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innov...

SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innov...

SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innov...

HANGZHOU, China, June 1, 2024 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("ZEEKR" ...